Spry Tirzepatide Review: Price Unit & Cancellation Terms

Spry lists tirzepatide at $299, but its public product information does not clearly attach a billing period or supply length to that amount. Treat it as a listed amount requiring clarification, rather than a verified $299 monthly subscription or a complete prescription quote.³

Confirm what the price buys

Before paying, ask whether $299 covers a single shipment, a defined treatment period, consultation charges, supplies and shipping. Also confirm whether a deposit is collected, when any remaining balance is charged, and whether renewal is automatic. The named tirzepatide entry alone does not establish patient eligibility, the selected preparation or a final all-in total.^3,5

Spry’s linked terms, dated October 16, 2024, say that when a partial payment is made, such as for medication, the remaining balance is charged after telehealth approval. They do not specify a universal deposit, remaining amount or renewal frequency. Obtain those figures for the actual plan you are considering.⁴

Cancellation has service-stage limits

The terms allow cancellation before product shipment or consultation services. They describe refunds for cancellation before services are rendered, with an exception for nonrefundable medical consultation fees. Partially completed services are not refundable unless the law requires otherwise. This is more limited than a general “cancel anytime for a full refund” promise.⁴

The practical question is what has already happened when you cancel: consultation, prescription preparation, shipment or another service. Ask Spry to identify the applicable cutoff and any nonrefundable amount in writing. The public terms do not establish a guaranteed refund processing time or an unconditional return right for dispensed medication.⁴

Clinical and pharmacy details still matter

The terms describe telehealth approval and do not guarantee medical outcomes. They identify Spry as formerly Victory Health Medical Group, but that does not identify your assigned clinician or dispensing pharmacy. Confirm the clinician’s role, state eligibility, pharmacy, preparation and supply before you proceed. A public company name or general quality statement is not independent proof of current credentials or an individual assignment.⁴

Keep drug evidence separate from service claims

Compounded tirzepatide is not an FDA-approved finished drug. Brand-drug trials do not establish outcomes for this platform or compounded preparation. SURMOUNT-1 and SURMOUNT-5 provide treatment context, not a promise about Spry’s product or your results.^1,2

Spry’s listed amount can start a comparison, but the missing price unit is material. The useful next step is a written plan showing the supply period, payment stages, cancellation charges and the clinical and dispensing parties—not an assumption that a bare price includes every part of care.

Further reading

whether compounded tirzepatide is still legal in 2026, Zepbound side effects, the gallbladder risk, thyroid cancer warning, tirzepatide evidence guide, StackMD, Ondra Health, best tirzepatide providers.